Dementia India Alliance and Apollo AyurVAID Hospitals sign MoU

IMT News Desk
IMT News Desk
· 2 min read
filter: 0; fileterIntensity: 0.0; filterMask: 0; module: photo; hw-remosaic: false; touch: (-1.0, -1.0); modeInfo: ; sceneMode: 8; cct_value: 4602; AI_Scene: (-1, -1); aec_lux: 293.60162; aec_lux_index: 0; hist255: 0.0; hist252~255: 0.0; hist0~15: 0.0; albedo: ; confidence: ; motionLevel: 0; weatherinfo: null; temperature: 46;

The two organisations will work towards creating awareness that encourages timely medical help, facilitates early diagnosis, and better management of the condition

Dementia India Alliance (DIA) and Apollo AyurVAID have joined hands to advance integrative dementia care and awareness in India. The collaboration aims to address the growing public health challenge posed by dementia by combining DIA’s expertise in care, community engagement and advocacy with Apollo AyurVAID’s clinical leadership in precision Ayurveda and integrative medicine. Together, the two organisations will work towards creating awareness that encourages timely medical help, facilitates early diagnosis, and better management of the condition.

Rajiv Vasudevan, Founder & Managing Director, Apollo AyurVAID Hospitals, said, “Dementia represents one of India’s most pressing yet under-addressed health challenges. Ayurveda, with its prowess in Jara Chikitsa(elder care) and Rasayana Chikitsa(promotive health) offers a preventive, promotive and disease-modifying framework that can delay dementia onset and progression particularly in the early stages by addressing the underlying metabolic, inflammatory, and cognitive imbalances that drive neurodegeneration. Apollo AyurVAID will also implement specialised training and dementia-friendly protocols across its centres to enhance patient experience and promote healthy ageing. This partnership is a decisive step toward ensuring that ageing in India is healthy, dignified, and well-supported.”

Dr Radha S Murthy , President, Dementia India Alliance, said, “We have been at the forefront of addressing the multifaceted challenges of dementia care, working to enhance the well-being of individuals and families through compassionate care, awareness, and structured community support. Our partnership with Apollo AyurVAID Hospitals is uniquely positioned to combine Ayurveda’s systems-based, whole-person approach with community outreach, advocacy and training to create an integrative model focused on prevention, early detection, and whole-person-health management. We will advance the development of integrative risk assessment and therapeutic protocols that combine Ayurveda principles of whole-person-care with modern clinical insights on physical, cognitive, and lifestyle factors, as well as the impact of polypharmacy and environmental variables. Through community education, workshops, and capacity-building programs, this initiative will equip families and practitioners with tools for prevention, early identification, and compassionate management. Our partnership with Apollo AyurVAID Hospitals is a strategic step to bridge systemic gaps and build a more dementia-inclusive healthcare ecosystem in India.”

Read Next

Centre Reaffirms Commitment to Building Healthcare Infrastructure Across Northeast India; Nadda Inaugurates Super-Specialty Hospital in Meghalaya
News
June 5, 2026

Centre Reaffirms Commitment to Building Healthcare Infrastructure Across Northeast India; Nadda Inaugurates Super-Specialty Hospital in Meghalaya

Union Health Minister J P Nadda on Thursday declared that the Central Government remains firmly committed to strengthening healthcare infrastructure across the Northeast and ensuring that advanced medical services reach people living in remote and underserved areas of the region. Nadda made these remarks while inaugurating ARHI Hospital in Meghalaya’s Ri-Bhoi district- a new super-specialty […]
Article by: IMT News Desk
Hexagon Nutrition Raises Rs 41.66 Crore from Anchor Investors Ahead of Rs 139-Crore IPO Opening Today
News
June 5, 2026

Hexagon Nutrition Raises Rs 41.66 Crore from Anchor Investors Ahead of Rs 139-Crore IPO Opening Today

Mumbai-based Hexagon Nutrition Ltd has mobilised Rs 41.66 crore from anchor investors ahead of its initial public offering (IPO), which opened for public subscription on June 5 and will remain open until June 9, 2026. According to a circular uploaded on BSE’s website, the company allotted a total of 92.57 lakh equity shares to anchor […]
Article by: IMT News Desk
Otsuka’s Voyxact Shows Kidney Function Preservation in Late-Stage IgAN Trial, Setting Stage for Full FDA Approval
News
June 5, 2026

Otsuka’s Voyxact Shows Kidney Function Preservation in Late-Stage IgAN Trial, Setting Stage for Full FDA Approval

Otsuka Pharmaceutical has reported that its approved kidney disease drug Voyxact (sibeprenlimab) preserved kidney function over 12 months in a late-stage clinical study, marking a significant milestone in the treatment of immunoglobulin A nephropathy (IgAN), a serious autoimmune condition that progressively damages the kidneys. In the Phase 3 VISIONARY trial involving 320 participants, patients who […]
Article by: IMT News Desk
Akums Receives European CEP Approval for Cefpodoxime Proxetil
News
June 4, 2026

Akums Receives European CEP Approval for Cefpodoxime Proxetil

Akums Drugs & Pharmaceuticals Ltd. has received a Certificate of Suitability (CEP) from the European Directorate for the Quality of Medicines & HealthCare (EDQM) for its active pharmaceutical ingredient (API), Cefpodoxime Proxetil. The CEP certification confirms that Akums’ manufacturing process and quality standards for Cefpodoxime Proxetil comply with the requirements of the European Pharmacopoeia. The […]
Article by: IMT News Desk